NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

"About market cap"....No, not really.

Northwest Biotherapeutics Inc. (NWBO) voluntarily withdrew its common stock from listing on the Nasdaq stock exchange, and switched to the OTCQB Venture Market (the “OTCQB”), commonly called the OTC market. (For more, see What Are the Advantages and Disadvantages of Listing on Nasdaq?)

On November 7, the Nasdaq staff notified the company that they have identified a few financing transactions completed between May 15, 2016 and October 13, 2016 that did not adhere to Nasdaq rules. Northwest then initiated remediation discussions, but the company’s remediation plans were rejected by the Nasdaq staff. The recent development to switch from Nasdaq to OTC is a fallout of that rejection.


OTC listing will also offer savings through reduced exchange costs, though it will come at the price of REDUCED transparency.

Read more: Northwest Biotherapeutics Shunted to OTC (NWBO) | Investopedia http://www.investopedia.com/news/northwest-biotherapeutics-shunted-otc-nwbo/#ixzz4YOpQBvsc
Follow us: Investopedia on Facebook